{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:50:05Z","timestamp":1772088605042,"version":"3.50.1"},"reference-count":47,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.1080\/13696998.2022.2035131","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T09:58:32Z","timestamp":1643623112000},"page":"238-248","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the cost and medical resource use outcomes associated with nasal glucagon versus injectable glucagon for treatment of severe hypoglycemia in people with diabetes in Canada: a modeling analysis"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7833-9050","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Yale","sequence":"first","affiliation":[{"name":"Department of Medicine, McGill University Health Center, McGill University, Montr\u00e9al, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5862-9325","authenticated-orcid":false,"given":"Beatrice","family":"Osumili","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Limited, Bracknell, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8583-6303","authenticated-orcid":false,"given":"Beth D.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, IN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5420-279X","authenticated-orcid":false,"given":"Barnaby","family":"Hunt","sequence":"additional","affiliation":[{"name":"Ossian Health Economics and Communications, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0808-2939","authenticated-orcid":false,"given":"Gurjeev","family":"Sohi","sequence":"additional","affiliation":[{"name":"Eisai Limited, Mississauga, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Jeddi","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Mojdami","sequence":"additional","affiliation":[{"name":"Eli Lilly Canada Inc., Toronto, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Valentine","sequence":"additional","affiliation":[{"name":"Ossian Health Economics and Communications, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31669"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f4533"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-2054"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12844"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2017-000503"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2017.01.007"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1600"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/1932296819831695"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0339"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0279"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2007.05.003"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2015.1006730"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13208"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2019.07.124"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2017.10.010"},{"key":"e_1_3_4_17_1","unstructured":"Eli Lilly Canada Inc. GLUCACON (rDNA Origin) Product Monograph [cited 2020 Apr 3]. Available from: https:\/\/www.lilly.ca\/en\/pdf\/consumer-information\/04_rglucagon-ci_9july2012.pdf"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/pdi.138"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814557518"},{"key":"e_1_3_4_20_1","unstructured":"Eli Lilly Canada Inc. BAQSIMI\u2122 glucagon nasal powder Product Monograph [cited 2020 Apr 3]. http:\/\/pi.lilly.com\/ca\/baqsimi-ca-pm.pdf"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1606"},{"key":"e_1_3_4_22_1","unstructured":"Pack BW Melnick JP Breen CC et\u00a0al. (IP11) Portability of nasal glucagon for the rescue of severe hypoglycemia: Stability and performance when exposed to temperature extremes. Association of Diabetes Care & Education Specialists. 2021 Annual Conference; Virtual; August 12\u201315; 2021."},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1498"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2016.0460"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/db19-13-LB"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13278"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12668"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/10903127.2018.1504150"},{"key":"e_1_3_4_29_1","unstructured":"Statistics Canada. Families households and marital status: key results from the 2016 Census [cited 2019 Jun 4]. Available from: https:\/\/www150.statcan.gc.ca\/n1\/daily-quotidien\/170802\/dq170802a-eng.htm"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2015.09.084"},{"key":"e_1_3_4_31_1","unstructured":"Ontario Drug Benefit Formulary\/Comparative Drug Index [cited 2019 Jun 4]. Available from: https:\/\/www.formulary.health.gov.on.ca\/formulary\/results.xhtml?q=glucagon&type=1"},{"key":"e_1_3_4_32_1","unstructured":"Toronto Paramedic Service. Annual report 2017 [cited 2019 Jun 4]. Available from: https:\/\/www.toronto.ca\/wp-content\/uploads\/2018\/03\/9730-Toronto-Paramedic-Services-Annual-Report-2017-sm.pdf"},{"key":"e_1_3_4_33_1","unstructured":"Government of Ontario. Ontario Case Costing Initiative (OCCI) [cited 2019 Jun 4]. Available from: https:\/\/www.ontario.ca\/data\/ontario-case-costing-initiative-occi"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.03.002"},{"key":"e_1_3_4_35_1","unstructured":"Statistics Canada. Labour force survey estimates (LFS) wages of employees by type of work National Occupational Classification for Statistics (NOC-S) sex and age group unadjusted for seasonality [cited 2019 Jun 4]. Available from: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1410006101&pickMembers%5B0%5D=1.1&pickMembers%5B1%5D=2.2&pickMembers%5B2%5D=3.1&pickMembers%5B3%5D=5.1&pickMembers%5B4%5D=6.1"},{"key":"e_1_3_4_36_1","unstructured":"Ministry of Health and Long Term Care. Schedule of benefits [cited 2021 Jun 28]. Available from: http:\/\/www.health.gov.on.ca\/en\/pro\/programs\/ohip\/sob\/physserv\/sob_master20181115.pdf"},{"key":"e_1_3_4_37_1","unstructured":"Ontario Drug Benefit Formulary\/Comparative Drug Index [cited 2019 Jun 4]. Available from: https:\/\/www.formulary.health.gov.on.ca\/formulary\/results.xhtml?q=glucose%2Bstrip&type=2"},{"key":"e_1_3_4_38_1","unstructured":"Canadian Agency for Drugs and Technologies in Health. Guidance document for the costing of health care resources in the Canadian setting. 2nd ed. [cited 2019 Jun 4]. Available from: https:\/\/www.cadth.ca\/guidance-document-costing-process-2e"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(89)80642-0"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2016.08.034"},{"key":"e_1_3_4_41_1","unstructured":"Alberta Health Services. Quarterly Emergency Medical Services Dashboard [cited 2019 Jun 4]. Available from: https:\/\/www.albertahealthservices.ca\/assets\/about\/ems\/ahs-ems-dashboard.pdf"},{"key":"e_1_3_4_42_1","unstructured":"Food and Drug Administration. ZEGALOGUE (dasiglucagon) injection for subcutaneous use: Prescribing information [cited 2022 Jan 16]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2021\/214231Orig1s000lbl.pdf"},{"key":"e_1_3_4_43_1","unstructured":"Food and Drug Administration. GVOKE (glucagon) injection for subcutaneous use: prescribing information [cited 2022 Jan 16]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/212097Orig1s000lbl.pdf"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/1932296819826577"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2013.09.001"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X115757"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X61929"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-90"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2022.2035131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T11:21:53Z","timestamp":1729164113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2022.2035131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1080\/13696998.2022.2035131"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2022.2035131","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-09-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}